Decreased CERS2 protein levels were also reported for the hypomyelination pathology in Niemann–Pick type C disease [146], and, interestingly, they were observed to precede tau pathology at a preclinical stage of Alzheimer’s disease [111]. This evidence concerns the gene CERS2 and Alzheimer disease.